HSBC HOLDINGS PLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$1,351,000
+90.0%
6,2250.0%0.00%
+100.0%
Q4 2020$711,000
+16.6%
6,2250.0%0.00%0.0%
Q3 2020$610,000
-81.7%
6,225
-77.1%
0.00%
-83.3%
Q2 2020$3,341,000
+42.0%
27,2250.0%0.01%
+20.0%
Q1 2020$2,353,000
-17.4%
27,2250.0%0.01%0.0%
Q4 2019$2,850,000
-54.5%
27,225
-50.0%
0.01%
-58.3%
Q3 2019$6,263,000
-33.3%
54,4490.0%0.01%
-33.3%
Q2 2019$9,386,000
+80.5%
54,449
+2.0%
0.02%
+80.0%
Q4 2018$5,199,000
-44.7%
53,388
-1.9%
0.01%
-33.3%
Q3 2018$9,406,000
+23.8%
54,4490.0%0.02%
+7.1%
Q2 2018$7,598,000
+147.7%
54,449
+100.0%
0.01%
+180.0%
Q1 2018$3,067,000
-57.3%
27,225
-50.0%
0.01%
-50.0%
Q4 2017$7,188,000
+3080.5%
54,449
+2347.1%
0.01%
Q3 2017$226,000
-91.7%
2,225
-91.8%
0.00%
-100.0%
Q2 2017$2,729,000
-17.1%
27,2250.0%0.01%
-28.6%
Q1 2017$3,293,000
+8.2%
27,225
-0.0%
0.01%0.0%
Q4 2016$3,043,000
+660.8%
27,229
+521.7%
0.01%
+600.0%
Q3 2015$400,0004,3800.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders